A center to support the adoption of effective interventions for substance use disorders and pain management.
HD2A Research Adoption Support Center (RASC)
This study is working on a new support center to help reduce overdose deaths in the U.S. by making sure that proven treatments for substance use and pain management are easier for people to access, so you can get the help you need more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10904707 on NIH RePORTER |
What this research studies
This research focuses on creating a support center aimed at reducing overdose deaths in the U.S. by translating evidence-based interventions for substance use disorders and pain management into practice. The center will utilize dissemination and implementation science to bridge gaps between scientific findings and public health applications. It will involve multiple cores that assess current intervention projects, provide support for implementation, and evaluate outcomes to ensure effectiveness. Patients may benefit from improved access to effective treatments and interventions tailored to their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals struggling with substance use disorders or chronic pain who are seeking effective treatment options.
Not a fit: Patients who are not affected by substance use disorders or chronic pain may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in overdose deaths and improved treatment options for individuals with substance use disorders.
How similar studies have performed: Previous research has shown promise in using dissemination and implementation science to improve health outcomes, indicating that this approach could be effective.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mcgovern, Mark P — Stanford University
- Study coordinator: Mcgovern, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.